Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Statin Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108033899B reveals a safe, ambient-temperature route for Atorvastatin intermediates. Discover cost reduction and supply chain advantages.
Novel KmAKR mutants enable high-yield enzymatic synthesis of rosuvastatin side chains, offering superior stability and cost-effective manufacturing solutions.
Patent CN112899246B details novel KmAKR mutants for synthesizing chiral statin side chains with superior stability and stereoselectivity for API manufacturing.
Patent CN101962661B reveals high-efficiency carbonyl reductase for statin intermediates. Offers superior yield and cost reduction in pharmaceutical intermediate manufacturing.
Discover the advanced CN1446088A process for highly purified simvastatin. Achieve superior impurity control and cost efficiency in statin manufacturing with our expert insights.